cb7b00113_si_001.pdf (6.44 MB)

O‑GlcNAcylation of α‑Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding

Download (6.44 MB)
journal contribution
posted on 14.02.2017, 00:00 by Yuka E. Lewis, Ana Galesic, Paul M. Levine, Cesar A. De Leon, Natalie Lamiri, Caroline K. Brennan, Matthew R. Pratt
The aggregation of neurodegenerative-disease associated proteins can be affected by many factors, including a variety of post-translational modifications. One such modification, O-GlcNAcylation, has been found on some of these aggregation prone proteins, including α-synuclein, the major protein that plays a causative role in synucleinopathies like Parkinson’s disease. We previously used synthetic protein chemistry to prepare α-synuclein bearing a homogeneous O-GlcNAc modification at threonine 72 and showed that this modification inhibits protein aggregation. However, the effects of the other eight O-GlcNAcylation sites that have been identified were unknown. Here, we use a similar synthetic strategy to investigate the consequences of this modification at one of these sites, serine 87. We show that O-GlcNAcylation at this site also inhibits α-synuclein aggregation but to a lesser extent than that for the same modification at threonine 72. However, we also find that this modification does not affect the membrane-binding properties of α-synuclein, which differentiates it from phosphorylation at the same site. These results further support the development of therapies that can elevate O-GlcNAcylation of α-synuclein to slow the progression of Parkinson’s disease.